Are American Institutions the Breeding Ground for Intellectual Property Theft?

By: Phillip Jester, Summer Blogger recent White House report accused China, the world’s second-largest economy, of engaging in aggressive “acts, policies, and practices that fall outside of global norms and rules.” The report highlights a new threat posed by China: the presence of “Chinese Nationals” serving as “Non-Traditional Information Collectors” at American universities.  The White House alleges that the Chinese State has created educational programs which encourage science and engineering students to master important military technologies in order to share such technologies with Beijing.

More than 100 American universities currently collaborate with Confucius Institutes, educational organization that are sponsored by China’s Communist Party.  Lawmakers and intelligence officials are now speaking out against the role of Confucius Institutes as possible “spying outposts.” In February, Federal Bureau of Investigation (“FBI”) Director Christopher Wray stated that Chinese spies are being planted in American schools in order to exploit “very open research and development” environments.  The exploitation of open educational environments may already be paying off.  Chinese Scientists returning from American laboratories have played a key role in the development of hypersonic glide systems, systems capable of penetrating any current missile defense. Continue reading »

The Evolution of Patent-Agent Privilege

By: Matthew Welch, Summer Blogger privilege is the keystone of the legal system that has been in place since the inception of the United States.  This privilege protects confidential communications between an attorney and his or her client. The purpose, put forth by the courts, for allowing these communications to be protected is that it “encourage[s] full and frank communication between attorneys and their clients.”  Thus, without this protection, clients would be less than forthcoming since all communications with their attorneys could potentially be used against them in future litigation.  However, a problem has arisen over the years regarding a specific application of attorney-client privilege.  That problem is patent-agent privilege.     Continue reading »

Tesla’s Environmentally-Friendly Image may be Tarnished by Legally-Unfriendly Disputes

Tesla Motors

By: Nathaniel Reiff, Summer Blogger

As today’s consumer seeks new and innovative ways to save money and preserve the environment, it may be a while until they achieve this objective with the cars they drive. Tesla Inc., the American international corporation renowned for its electric vehicle production, has been hit with a score of lawsuits that could put the energy-giant in a nasty predicament.

Last October, shareholders filed a securities fraud lawsuit claiming Tesla gave false public statements about the progress of producing its Model 3 sedan. The complaint identifies that shareholders bought “artificially inflated” shares of Tesla because Elon Musk, Tesla’s Chief Executive Officer, and other executives misled them with such statements. Tesla counters that since the vehicle was “the first of its kind,” the company had experienced numerous “bottlenecks.” The company said it provided the shareholders in “frank and in plain language” that the challenges the company faced with the Model 3 derived from problems with the battery module process at its Nevada Gigafactory to general assembly at its Fremont plant. Continue reading »

Employee Tracking: How to Balance Business Efficiency and the Right to Privacy

By: Christopher Lewis *| Staff Writer

By Rama (Own work) [CeCILL ( or CC BY-SA 2.0 fr (], via Wikimedia Commons

By Rama (Own work) [CeCILL ( or CC BY-SA 2.0 fr (], via Wikimedia Commons

With the advent of new technology, privacy concerns are becoming an increasingly hot topic of debate in many different forms. People across the globe are becoming more cognizant of the personal right to privacy and are working to protect it; however, other factions believe that technological advances and the integration of life and technology are worth the loss in privacy rights. Some believe that it is only a matter of time before we fall into the dystopian worlds that George Orwell and Ray Bradbury, respectfully, espoused in 1984 and Fahrenheit 451. Continue reading »

Spring 2018 Symposium: Intellectual Property & Medical Technology: From Creation to Commercialization


The Wake Forest Journal of Business and Intellectual Property Law present its Spring Symposium:

Intellectual Property and Medical Technology: From Creation to Commercialization 

The Symposium is being held, today, Friday, February 2, 2018, from 8:30 am – 4:00 pm at the Wake Forest Innovation Quarter (Biotech Place). This year’s event will look at medical patents, bioethics and the intellectual property implications of medical technology.


Overview of Regenerative Medicine, Role of Law, & Bioethics

Keynote Speakers: Julie Watson and Dr. John D. Jackson

Julie Watson, Chief Legal Counsel for the Institute for Regenerative Medicine at the Wake Forest School of Medicine, opened the Wake Forest Journal of Business and Intellectual Property Law Symposium by introducing the first speaker of the day, Dr. John D. Jackson. Dr. Jackson, an associate professor at the Institute since 2010, began the day’s events by explaining the technical components of the Institute.

Continue reading »

A General Overview of the Journal of Business and Intellectual Property Law’s Symposium: “Intellectual Property and Medical Technology: From Creation to Commercialization”

By Justfixingawrongnumber (Own work) [CC0], via Wikimedia Commons

By Justfixingawrongnumber (Own work) [CC0], via Wikimedia Commons

The Wake Forest Journal of Business and Intellectual Property Law will be hosting its spring symposium,  “Intellectual Property and Medical Technology: From Creation to Commercialization,” beginning at 8:30 a.m. this Friday, February 2, 2018, in the Wake Forest Biotech Place Atrium at Wake Forest Innovation Quarter. Medical patents, the intersection of bioethics and the law, and the venture capitalist-side of regenerative medicine are among some of the topics to be discussed at this year’s symposium. This blog post is meant to provide a brief overview of bioethics and venture capitalists of medical devices.

Continue reading »

Native American Tribe Makes Huge Gamble in Patents Litigation

By: Jamie Burchette *| Staff Writer

By Xasartha (Own work) [CC BY-SA 3.0 (], via Wikimedia Commons

By Xasartha (Own work) [CC BY-SA 3.0 (], via Wikimedia Commons

Native American tribes were sovereign nations long before Europeans arrived in America. Eventually, European settlers pushed Native American tribes into smaller and smaller pieces of land and their sovereign power was weakened. While the Native American tribes’ existence as an independent nation was recognized in Cherokee Nation v. Georgia, the U.S. Government’s treatment of the Native American tribes was less than respectful. Native Americans continued to lose their land and have their culture attacked. Things changed, somewhat, with the introduction of the Indian Reorganization Act of 1934. The U.S. Government recognized the Native American’s tribal sovereignty and stopped taking Native American land.

Continue reading »

The New Battlefield: Regular and Established Place of Business

By: Gilbert Smolenski *| Guest Writer

Under the patent venue statute, 28 U.S.C. § 1400(b), venue is proper: (1) where a defendant resides or (2) where a defendant has committed an act of infringement and has a regular and established place of business. From 1990 until May 22, 2017, “resides” was interpreted by the Federal Circuit to take on the same meaning as “resides” in § 1391(c). Therefore, so long as the court had personal jurisdiction over the defendant, venue was proper. On May 22, 2017, however, the United States Supreme Court reversed the Federal Circuit in TC Heartland v. Kraft Food Group Brands, holding that “resides” refers only to the state of incorporation for domestic corporations. This reasserted the Supreme Court’s earlier interpretation of “resides” from Fourco Glass Co. v. Transmirre Products Corp., and consequently opened the door to a new battlefield for patent litigation, specifically the meaning of “regular and established place of business.”

Continue reading »

Rock Band Disrupts Intellectual Property Law

By: Andrew Homer *| Guest Writer

By This image or media was taken or created by Matt H. Wade. To see his entire portfolio, click here. @thatmattwade     This image is protected by copyright! If you would like to use it, please read this first. (Own work) [CC BY-SA 3.0 (], via Wikimedia Commons

By This image or media was taken or created by Matt H. Wade. To see his entire portfolio, click here. @thatmattwade This image is protected by copyright! If you would like to use it, please read this first. (Own work) [CC BY-SA 3.0 (], via Wikimedia Commons

The Supreme Court recently ruled that the United States Patent and Trademark Office (USPTO) cannot deny the registration of a trademark because some may find the mark disparaging or offensive. The case that led to the ruling, Matal v. Tam, upended a 70-year-old tradition of federal trademark law found in 15 U.S.C. §1052 (a) and commonly named the disparagement clause. The Court holding that the disparagement clause is unconstitutional will have broad reaching effects to other aspects of intellectual property law and the nature of the corporation.

Continue reading »

Lexmark: A Closer Look at the Patent Exhaustion Doctrine when Articles are Sold Outside the U.S.

By: Katherine Escalante*| Staff Writer March 21, 2017, the Supreme Court heard oral arguments in Lexmark International, Inc. v. Impression Products, Inc. relating to the doctrine of patent exhaustion. While the opinion is not yet available, the Supreme Court’s decision is expected to become a pivotal decision on the application of the patent exhaustion doctrine. The Supreme Court will review the Federal Circuit’s en banc decision finding: “(1) the first sale doctrine does not apply to patented articles sold subject to restrictions . . .; and (2) the first sale doctrine does not apply to patented articles sold outside of the United States.”

Continue reading »